Cardiac Resynchronization Therapy Market is segmented By Product Type (CRT-Defibrillators, CRT-Pacem...
Market Size in USD Bn
CAGR6.6%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.6% |
Market Concentration | High |
Major Players | Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK, Microport Scientific Corporation and Among Others |
The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.94 billion in 2025 and is expected to reach USD 12.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. Advancements in cardiac devices along with the rising geriatric population suffering from chronic heart conditions are major factors driving the growth of this market.